Pritor | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Pritor
EDQM

PharmaCompass Sponsored Ads

Contact Supplier

Telmisartan RM

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Aspen API. More than just an API™

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Pritor

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

160 API Suppliers, 40 USDMF, 43 CEP/COS, 18 JDMF, 36 EU WC, 45 KDMF, 21 NDC API, 73 Listed Suppliers, $ API Reference Price

160 API Suppliers
40 USDMF
43 CEP/COS
18 JDMF
36 EU WC
45 KDMF
21 NDC API
73 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

53 Intermediate Suppliers

53 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

941 FDF Dossiers, 113 FDA Orange Book, 410 Europe, 62 Canada, 28 Australia, 73 South Africa, 255 Listed Dossiers

941 FDF Dossiers
113 FDA Orange Book
410 Europe
62 Canada
28 Australia
73 South Africa
255 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 80MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;80MG, TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG
TABLET;ORAL - 40MG
TABLET;ORAL - 80MG
TABLET;ORAL - 12.5MG;40MG
TABLET;ORAL - 12.5MG;80MG
TABLET;ORAL - 25MG;80MG
TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 19 SPI Pharma, 4 DKSH, 6 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 14 BASF, 10 Corel Pharma Chem, 7 DFE Pharma, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 44 Disintegrants & Superdisintegrants, 36 Direct Compression, 26 Granulation, 23 Controlled & Modified Release, 20 Chewable & Orodispersible Aids, 19 Thickeners and Stabilizers, 19 Taste Masking, 18 Lubricants & Glidants, 17 Co-Processed Excipients, 15 Film Formers & Plasticizers, 11 Solubilizers, 9 Parenteral, 5 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Coloring Agents, 1 Soft Gelatin

87 Fillers, Diluents & Binders
44 Coating Systems & Additives
44 Disintegrants & Superdisintegrants
36 Direct Compression
26 Granulation
23 Controlled & Modified Release
20 Chewable & Orodispersible Aids
19 Thickeners and Stabilizers
19 Taste Masking
18 Lubricants & Glidants
17 Co-Processed Excipients
15 Film Formers & Plasticizers
11 Solubilizers
9 Parenteral
5 Rheology Modifiers
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
4 Emulsifying Agents
3 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

41 News #PharmaBuzz

41 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 372 Regulatory FDF Prices, 7 Annual Reports

2 US Medicaid Prescriptions
372 Regulatory FDF Prices
7 Annual Reports

MARKET PLACE

35 APIs, 12 FDF Dossiers

35 APIs
12 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 16 Others

3 EDQM
16 Others

ANALYTICAL

2 BioAnalytical Methods, 2 Analytical Methods

2 BioAnalytical Methods
2 Analytical Methods

$ API Ref.Price (USD/KG) : 146 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

3 All

01 1Y0000648

02 1Y0000649

03 1Y0001003

filter CAS Number Reset all filters

3 All

01 3144701-48-4

filter Reference Standard Reset all filters

3 All

01 1Telmisartan

02 1Telmisartan for peak identification

03 1Telmisartan for system suitability

Octavius Telmisartan

Product Main Page

01

EDQM, Council of Europe

Telmisartan

PEGS Boston Summit

Not Confirmed

01

EDQM, Council of Europe

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Telmisartan

CAS Number : 144701-48-4

Quantity Per Vial : 30 mg

Sale Unit : 1

Order Code : Y0000648

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Telmisartan for peak identification

PEGS Boston Summit

Not Confirmed

02

EDQM, Council of Europe

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Telmisartan for peak identification

CAS Number : 144701-48-4

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0000649

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Telmisartan for system suitability

PEGS Boston Summit

Not Confirmed

03

EDQM, Council of Europe

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Telmisartan for system suitability

CAS Number : 144701-48-4

Quantity Per Vial : 0.26 mg

Sale Unit : 1

Order Code : Y0001003

Batch No : 4

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!